scPharmaceuticals Inc. (SCPH) Operating Income (Loss) USD 2017 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
scPharmaceuticals Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2017 to 2024.
  • scPharmaceuticals Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$15.9 M, a 37.2% decline year-over-year.
  • scPharmaceuticals Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$59.7 M, a 47.5% decline year-over-year.
  • scPharmaceuticals Inc. annual Operating Income (Loss) for 2023 was -$55.4 M, a 53.2% decline from 2022.
  • scPharmaceuticals Inc. annual Operating Income (Loss) for 2022 was -$36.2 M, a 40% decline from 2021.
  • scPharmaceuticals Inc. annual Operating Income (Loss) for 2021 was -$25.8 M, a 13.7% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$59.7 M -$15.9 M -$4.3 M -37.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$55.4 M -$15.3 M -$5.76 M -60.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 -$49.6 M -$14.8 M -$4.84 M -48.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$44.8 M -$13.7 M -$4.33 M -45.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 -$40.5 M -$11.6 M -$4.31 M -59.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$36.2 M -$9.5 M -$2.78 M -41.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 -$33.4 M -$10 M -$4.09 M -69.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$29.3 M -$9.42 M -$2.97 M -45.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$26.3 M -$7.24 M -$499 K -7.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$25.8 M -$6.72 M +$449 K +6.26% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 -$26.3 M -$5.91 M +$2.53 M +30% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$28.8 M -$6.46 M +$1.22 M +15.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$30 M -$6.74 M -$92 K -1.38% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$29.9 M -$7.17 M +$3.26 M +31.3% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-22
Q3 2020 -$33.2 M -$8.44 M -$2.15 M -34.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$31 M -$7.68 M -$341 K -4.65% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 -$30.7 M -$6.65 M +$2.2 M +24.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 -$32.9 M -$10.4 M -$5.21 M -99.8% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-23
Q3 2019 -$27.7 M -$6.29 M -$448 K -7.67% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$27.2 M -$7.34 M +$2.57 M +25.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$29.8 M -$8.85 M -$148 K -1.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q4 2018 -$29.7 M -$5.22 M +$1.49 M +22.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-24
Q3 2018 -$31.2 M -$5.84 M -$591 K -11.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$30.6 M -$9.9 M -$3.39 M -51.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$27.2 M -$8.7 M -$3.74 M -75.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 -$23.4 M -$6.71 M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-21
Q3 2017 -$5.25 M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$6.52 M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$4.96 M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.